Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Schellens, J.H.M.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(32)
+
-
Availability
Open access
(13)
+
-
Closed access
(1)
+
-
Metadata Only
(18)
+
-
Creation Date
2018
(6)
+
-
2019
(6)
+
-
2017
(4)
+
-
2015
(3)
+
-
2022
(3)
+
-
2016
(2)
+
-
2021
(2)
+
-
2023
(2)
+
-
Show more
Faculty
Faculty of Science
(3)
+
-
Leiden University Medical Center (LUMC)
(24)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(24)
+
-
Scholarly Publications
(5)
+
-
Leiden Academic Centre for Drug Research (LACDR)
(3)
+
-
Topic
DPYD
(4)
+
-
Dihydropyrimidine dehydrogenase
(3)
+
-
capecitabine
(3)
+
-
dihydropyrimidine dehydrogenase
(3)
+
-
pharmacogenomics
(3)
+
-
5-fluorouracil
(2)
+
-
Capecitabine
(2)
+
-
EGFR
(2)
+
-
Fluoropyrimidines
(2)
+
-
Pharmacogenetics
(2)
+
-
Toxicity
(2)
+
-
fluoropyrimidines
(2)
+
-
pharmacogenetics
(2)
+
-
Show more
Author
Schellens, J.H.M.
(32)
+
-
Beijnen, J.H.
(17)
+
-
Guchelaar, H.J.
(16)
+
-
Cats, A.
(15)
+
-
Meulendijks, D.
(15)
+
-
Henricks, L.M.
(13)
+
-
Gelderblom, H.
(12)
+
-
Swen, J.J.
(12)
+
-
Mathijssen, R.H.J.
(11)
+
-
Deenen, M.J.
(9)
+
-
Lunenburg, C.A.T.C.
(9)
+
-
Huitema, A.D.R.
(8)
+
-
Rosing, H.
(7)
+
-
Man, F.M. de
(5)
+
-
Creemers, G.J.
(4)
+
-
Hasselt, J.G.C. van
(4)
+
-
Imholz, A.L.T.
(4)
+
-
Kuilenburg, A.B.P. van
(4)
+
-
Mandigers, C.M.P.W.
(4)
+
-
Baars, A.
(3)
+
-
Burylo, A.M.
(3)
+
-
Droogendijk, H.J.
(3)
+
-
Knikman, J.
(3)
+
-
Nieboer, P.
(3)
+
-
Pluim, D.
(3)
+
-
Portielje, J.E.A.
(3)
+
-
Schaik, R.H.N. van
(3)
+
-
Steeghs, N.
(3)
+
-
Vries, N. de
(3)
+
-
With, M. de
(3)
+
-
Boer, A. de
(2)
+
-
Broek, D. van den
(2)
+
-
Dezentje, V.O.
(2)
+
-
Frederix, G.W.J.
(2)
+
-
Hamberg, P.
(2)
+
-
Jacobs, B.A.W.
(2)
+
-
Jansen, R.L.H.
(2)
+
-
Janssen, J.M.
(2)
+
-
Jeurissen, F.J.F.
(2)
+
-
Joerger, M.
(2)
+
-
Kienhuis, E.
(2)
+
-
Kloth, J.S.L.
(2)
+
-
Knikman, J.E.
(2)
+
-
Koopman, M.
(2)
+
-
Lopez-Yurda, M.
(2)
+
-
Nuijen, B.
(2)
+
-
Poel, M.H.W. van de
(2)
+
-
Tije, A.J. ten
(2)
+
-
Weger, V.A. de
(2)
+
-
Werkhoven, E. van
(2)
+
-
Yu, H.
(2)
+
-
Show more
Language
en
(31)
+
-
Search results
(1 - 24 of 32)
Pages
1
2
›
››
show grid
show list
save search
Survival of patients with cancer with DPYD variant alleles and dose-individualized fluoropyrimidine therapy
A nomogram to predict severe toxicity in DPYD wild-type patients treated with capecitabine-based anticancer regimens
Response to "Plasma Uracil as a DPD Phenotyping Test: Pre-analytical Handling Matters"
Response to "Plasma Uracil as a DPD Phenotyping Test: Pre-analytical Handling Matters"
Dihydropyrimidine dehydrogenase phenotyping using pretreatment uracil
Transtympanic sodium thiosulfate for prevention of cisplatin-induced ototoxicity
Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumors
Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive Analysis
A population pharmacokinetic model of oral docetaxel coadministered with ritonavir to support early clinical development
Effectiveness and safety of reduced-dose fluoropyrimidine therapy in patients carrying the DPYD*2A variant: A matched pair analysis
Comparison of toxicity and effectiveness between fixed-dose and body surface area-based dose capecitabine
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? reply
A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy
Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants
Food-effect study on uracil and dihydrouracil plasma levels as marker for dihydropyrimidine dehydrogenase activity in human volunteers
Standard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriers
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update
Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens
An LC-MS/MS method for quantification of the active abiraterone metabolite Delta(4)-abiraterone (D4A) in human plasma
Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies
Pharmacogenetic analysis of irreversible severe cisplatin-induced nephropathy: a case report of a 27-year-old woman
Letter regarding Zhao et al. entitled "DPYD gene polymorphisms are associated with risk and chemotherapy prognosis in pediatric patients with acute lymphoblastic leukemia"
Pages
1
2
›
››